145 related articles for article (PubMed ID: 20080487)
1. Growth factors as active participants in carcinogenesis: a perspective.
Halper J
Vet Pathol; 2010 Jan; 47(1):77-97. PubMed ID: 20080487
[TBL] [Abstract][Full Text] [Related]
2. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways.
Newton HB
Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of growth factor receptor kinase-dependent signaling pathways in anticancer chemotherapy--clinical progress.
Renhowe PA
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):214-24. PubMed ID: 11926128
[TBL] [Abstract][Full Text] [Related]
4. Growth factors and their receptors in metastasis.
Radinsky R
Semin Cancer Biol; 1991 Jun; 2(3):169-77. PubMed ID: 1655117
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and the epididymis.
Tomsig JL; Turner TT
J Androl; 2006; 27(3):348-57. PubMed ID: 16474016
[No Abstract] [Full Text] [Related]
6. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
7. Growth factors and their action in vivo and in vitro.
Gospodarowicz D
J Pathol; 1983 Nov; 141(3):201-33. PubMed ID: 6319652
[TBL] [Abstract][Full Text] [Related]
8. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
11. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
Lage A; Crombet T; González G
Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
[TBL] [Abstract][Full Text] [Related]
12. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
13. Role for platelet-derived growth factor-like and epidermal growth factor-like signaling pathways in gastrulation and spiculogenesis in the Lytechinus sea urchin embryo.
Ramachandran RK; Govindarajan V; Seid CA; Patil S; Tomlinson CR
Dev Dyn; 1995 Sep; 204(1):77-88. PubMed ID: 8563028
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
16. Maternal growth factor regulation of human placental development and fetal growth.
Forbes K; Westwood M
J Endocrinol; 2010 Oct; 207(1):1-16. PubMed ID: 20817666
[TBL] [Abstract][Full Text] [Related]
17. Rational bases for the development of EGFR inhibitors for cancer treatment.
Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents.
Holash J; Thurston G; Rudge JS; Yancopoulos GD; Adjei AA; Bergers G; Pytowski B; Pegram M; Gordon MS
Cancer Metastasis Rev; 2006 Jun; 25(2):243-52. PubMed ID: 16770536
[No Abstract] [Full Text] [Related]
19. Growth factors in preimplantation mammalian embryos.
Schultz GA; Heyner S
Oxf Rev Reprod Biol; 1993; 15():43-81. PubMed ID: 8336981
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
Cao Y; Zhong W
Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]